 |
|
|
|
|
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Sigurdsson E. on PAPER: Boutajangout A. et al., 2010, We thank Rakez for his comment.
Antibody response towards non-phosphorylated regions of the... 28 Dec 2010.
|
|
|
 |
|
|
Sigurdsson E. on PAPER: Clavaguera F. et al., 2009, Clavaguera and colleagues demonstrate in this elegant study that an injection of a brain extract... 16 Jun 2009.
|
|
|
|
|
|
Sigurdsson E. on PAPER: Asuni AA. et al., 2007, Andre Delacourte raises a good question about extracellular versus intracellular clearance. It... 7 Sep 2007.
|
|
|
|
|
|
Sigurdsson E. on PAPER: Racke MM. et al., 2005, The study by Racke and colleagues is the third report showing cerebral bleeding in different AD... 11 Feb 2005.
|
|
|
|
|
|
Sigurdsson E. on NEWS: A Potential Prion Therapy Focuses Attention on Protein Conversion, This is an elegant study that shows the importance of studying further the biological role of... 4 Nov 2003.
|
|
|
|
|
|
Sigurdsson E. on NEWS: Antibodies Found That Specifically Target Infectious Prions, The study by Paramithiotis and colleagues is meticulously performed and demonstrates that... 6 Jun 2003.
|
|
|
|
|
|
Frangione B, Sigurdsson E. on NEWS: Pertussis Toxin Stokes Autoimmune Reaction in Aβ-Vaccinated Mice, The adverse reactions of vaccines can have various and complex origins related to both the... 12 Feb 2003.
|
|
|
|
|
|
Frangione B, Sigurdsson E. on NEWS: One-Shot Deal? Mice Regain Memory Day After Vaccination, Plaques Stay Put, "The findings by Dodart and colleagues are very interesting. However, as Steven Paul points out... 12 Apr 2002.
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
